Praveen Tyle Insider Profile

4 Followers
Praveen Tyle, Director at Eyegate, holds 69.34K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 61.89K shares in Eyegate (Ticker: EYEG).
tipranks
Praveen Tyle

Praveen Tyle
Eyegate (EYEG)
Director

Not Ranked
Praveen Tyle has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$319K
64.75%
35.25%
A breakdown of Praveen Tyle's holdings

Insider Roles

Eyegate
(EYEG)
Director
Lexicon Pharmaceuticals
(LXRX)
EVP, R&D
Roles that Praveen Tyle holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Praveen Tyle

Praveen Tyle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eyegate
Jul 12, 2018
Director
Uninformative Buy
$206.35K
Lexicon Pharmaceuticals
Apr 24, 2020
EVP, R&D
Uninformative Buy
$112.34K
List of latest transactions for each holding click on a transaction to see Praveen Tyle's performance on stock

Praveen Tyle insider profile FAQ

What is the percentage of profitable transactions made by Praveen Tyle?
The percentage of profitable transactions made by Praveen Tyle is ―.
    What is the average return per transaction made by Praveen Tyle?
    The average return per transaction made by Praveen Tyle is ―.
      What stocks does Praveen Tyle hold?
      Praveen Tyle holds: EYEG, LXRX stocks.
        What was Praveen Tyle’s latest transaction?
        Praveen Tyle latest transaction was an Uninformative Buy of ―.
          What was Praveen Tyle's most profitable transaction?
          Praveen Tyle’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Praveen Tyle's role in Eyegate?
            Praveen Tyle's role in Eyegate is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.